学部生の岡さんの論文がInt J Clin Pharmに採択されました。

Adverse Events of Nivolumab plus Ipilimumab versus Nivolumab plus Cabozantinib: A Real-World Pharmacovigilance Study

Yurie Oka, Jun Matsumoto, Tatsuaki Takeda, Naohiro Iwata, Takahiro Niimura, Aya Fukuma Ozaki, Kensuke Bekku, Hirofumi Hamano, Motoo Araki, Keisuke Ishizawa, Yoshito Zamami, and Noritaka Ariyoshi